Document is current
Any future updates will be listed below
-
Authors
Upadhyay, Navneet
Ketkar, Amita
Mert, Can
Wallem, Alexandra
Baygani, Simin K.
Beyene, Tariku J.
Fisher, Deborah A.
Quimbo, Tracey
Perez, Raven A.
Grabner, Michael
Chapman, J. Casey
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 4 April 2025
Accepted: 8 April 2026
First Online: 20 June 2026
Declarations
:
: This study used secondary data from the Healthcare Integrated Research Database. No study subjects were contacted, and informed consent was not obtained. Data use agreements with covered entities were in place in accordance with the Health Insurance Portability and Accountability Act Privacy Rule; hence, Institutional Review Board approval was not required.
: Not applicable.
: NU, AW, SKB, and DAF are employees of Eli Lilly and Company and own restricted stocks of Eli Lilly and Company. AK, TJB, TQ, RP, and MG are employees of Carelon Research, which received funding from Eli Lilly and Company for the conduct of this study. AK, TJB, and MG are stockholders of Elevance Health, the parent company of Carelon Research. CM is a contractor of HaaPACS GmbH, which provides statistical support for Eli Lilly and Company. JCC is an employee of the GI Alliance and reports paid speaker and/or advisor work with AbbVie, BMS, Janssen, Lilly, Medtronic, and Takeda.
